DICOM PS3.3 2020b - Information Object Definitions

C.26.4 Substance Administration Log Module

Table C.26-4 specifies the Attributes used to record the act of administration of a contrast agent, drug, or device to a patient.

Table C.26-4. Substance Administration Log Module Attributes

Attribute Name

Tag

Attribute Description

Patient's Name

(0010,0010)

Patient's full name

Patient ID

(0010,0020)

Primary identification number or code for the patient.

Include Table 10-18 “Issuer of Patient ID Macro Attributes”

Admission ID

(0038,0010)

Identification number of the Visit as assigned by the healthcare provider

Issuer of Admission ID Sequence

(0038,0014)

Identifier of the Assigning Authority that issued the Admission ID.

Only a single Item shall be included in this Sequence.

>Include Table 10-17 “HL7v2 Hierarchic Designator Macro Attributes”

Product Package Identifier

(0044,0001)

Identifier of the contrast agent, drug, or device administered, typically from a package bar code, RFID, or other materials management ID. This ID might not be globally unique and might conflict with other IDs used within the scope of the institution.

Product Name

(0044,0008)

Trade or generic name of product.

Note

May be multi-valued.

Product Description

(0044,0009)

Text description of the contrast agent, drug, or device administered.

Substance Administration DateTime

(0044,0010)

Date and Time of Substance Administration

Substance Administration Notes

(0044,0011)

Comments provided by the operator responsible for the substance administration.

Substance Administration Device ID

(0044,0012)

Identifier for a device that controls substance administration, e.g., injector, infusion pump, etc.

Administration Route Code Sequence

(0054,0302)

Route of administration for drug or contrast.

Only a single Item shall be included in this Sequence.

>Include Table 8.8-1 “Code Sequence Macro Attributes”

BCID 11 “Route of Administration”.

Substance Administration Parameter Sequence

(0044,0019)

Parameters of the substance as administered to the patient, e.g., volume, quantity.

Zero or more Items shall be included in this Sequence.

>Include Table 10-2 “Content Item Macro Attributes Description”

For administration of drugs or contrast agents, Baseline Context Group for Concept Name Code Sequence is CID 3410 “Numeric Parameters of Drugs/Contrast”.

Operator Identification Sequence

(0008,1072)

Person administering the substance to the patient, or legally responsible for the administration, and authorized to add an entry to the Medication Administration Record.

One or more Items shall be included in this Sequence.

>Person Identification Code Sequence

(0040,1101)

Coded identifier of the person administering the contrast agent, drug, or device.

Only a single Item shall be included in this Sequence.

>>Include Table 8.8-1 “Code Sequence Macro Attributes”

No Baseline CID is defined.

The Coding Scheme Designator Attribute may indicate a local coding scheme (e.g., with value "L") when it is implicitly that of the institution's employee identifier system.

The Code Meaning Attribute, though it is encoded with a VR of LO, may be encoded according to the rules of the PN VR (see Section 10.1).


DICOM PS3.3 2020b - Information Object Definitions